Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study of Chemogenetic Gene Therapy With Adeno-Associated Virus for Parkinson's Disease Using Stereotactic Surgery in the Subthalamic Nucleus

NCT07533591 is registered in ClinicalTrials.gov with Second Affiliated Hospital, Zhejiang University, School of Medicine as lead sponsor.

NCT NCT07533591
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07533591 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study of Chemogenetic Gene Therapy With Adeno-Associated Virus for Parkinson's Disease Using Stereotactic Surgery in the Subthalamic Nucleus
Lead sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase
Phase 1
Overall status
Not yet recruiting
Start date
May 31, 2026
Completion date
April 30, 2029
Enrollment
6 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease (pd)